ADDERALL XR 30

LOE Approaching

dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate

Takeda
NDAORALCAPSULE, EXTENDED RELEASE
Approved
Oct 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

non-catecholamine sympathomimetic amines with CNS stimulant activity. The mode of therapeutic action in ADHD is not known.

Indications (2)

attention deficit hyperactivity disorder (ADHD) in adultsolder
Company
Takeda
Takeda
TOKYO, Japan
1309 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers